Why patients continue to participate in clinical research

Archives of Internal Medicine

Volumn 168, Issue 12, 2008, Pages 1294-1299

  Wendler, David ^a   Krohmal, Benjamin ^a   Emanuel, Ezekiel J ^a   Grady, Christine ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RECOMBINANT INTERLEUKIN 2; INTERLEUKIN 2;

ADULT; AGE DISTRIBUTION; ARGENTINA; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDUCATION; EMPLOYMENT; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOTIVATION; MULTICENTER STUDY; OPEN STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THAILAND; ALTRUISM; ATTITUDE TO HEALTH; CONTROLLED STUDY; MEDICAL RESEARCH; PATIENT ATTITUDE; PHASE 3 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT;

ADULT; ALTRUISM; ANTI-RETROVIRAL AGENTS; BIOMEDICAL RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; MALE; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 46449128132     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.12.1294     Document Type: Article

References (31)

1. Dunn LB, Candilis PJ, Roberts LW. Emerging empirical evidence on the ethics of schizophrenia research. Schizophr Bull. 2006;32(1):47-68.
2. Ross MW, Jeffords K, Gold J. Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study. AIDS Care. 1994;6(1):77-82.
3. Penman DT, Holland JC, Bahna GF, et al. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol. 1984;2 (7):849-855.
4. Newburg SM, Holland AE, Pearce LA. Motivation of subjects to participate in a research trial. Appl Nurs Res. 1992;5(2):89-104.
5. Rojavin MA, Downs P, Shetzline MA, Chilingerian R, Cohard-Radice M. Factors motivating dyspepsia patients to enter clinical research. Contemp Clin Trials. 2006; 27(2):103-111.
6. Lowton K. Trials and tribulations: understanding motivations for clinical research participation amongst adults with cystic fibrosis. Soc Sci Med. 2005; 61(8):1854-1865.
7. Warner TD, Roberts LW, Nguyen K. Do psychiatrists understand research-related experiences, attitudes, and motivations of schizophrenia study participants? Compr Psychiatry. 2003;44(3):227-233.
8. Lynöe N, Sandlund M, Dahlqvist G, Jacobsson L. Informed consent: study of quality of information given to participants in a clinical trial. BMJ. 1991;303 (6803):610-613.
9. Yuval R, Halon DA, Merdler A, et al. Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction. Arch Intern Med. 2000;160(8):1142-1146.
10. Hietanen P, Aro AR, Holli K, Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer. 2000;36(16):2096-2104.
11. Seelig BJ, Dobelle WH. Altruism and the volunteer: psychological benefit from participating as a research subject. ASAIO J. 2001;47(1):3-5.
12. Carey MP, Morrison-Beedy D, Carey KB, Maisto SA, Gordon CM, Pedlow CT. Psychiatric outpatients report their experiences as participants in a randomized clinical trial. J Nerv Ment Dis. 2001;189(5):299-306.
13. Pappworth MH. Human guinea pigs - a history. BMJ. 1990;301(6766):1456-1460.
14. Lemonick MD, Goldstein A. Human guinea pigs. http://www.time.com/time/ covers/1101020422/story.html. Accessed March 31, 2008.
15. Jonas H. Philosophical reflections on experimenting with human subjects. Daedalus. 1969;98:219-247.
16. Wertheimer A. Exploitation. Princeton, NJ: Princeton University Press; 1999.
17. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. Ethics: fair benefits for research in developing countries. Science. 2002;298(5601):2133-2134.
18. Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med. 2001;345(2):139-142.
19. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;17(2):20-24.
20. Lidz CW, Applebaum PS. The therapeutic misconception: problems and solutions. Med Care. 2002;40(9)(suppl):V55-V63.
21. Emery S, Abrams DI, Cooper DA, et al. The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design and methods of ESPRIT. Control Clin Trials. 2002;23(2):198-220.
22. Morris N, Balmer B. Volunteer human subjects' understandings of their participation in a biomedical research experiment Soc Sci Med. 2006;62(4):998-1008.
23. Sackett DL. Participants in research. BMJ. 2005;330(7501):1164.
24. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB. 2004;26(2):1-8.
25. Horng S, Grady C. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation and therapeutic optimism. IRB. 2003;25(1):11-16.
26. Candilis PJ, Geppert CM, Fletcher KE, Lidz CW, Appelbaum PS. Willingness of subjects with thought disorder to participate in research. Schizophr Bull. 2006; 32(1):159-165.
27. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001;358(9295):1772-1777.
28. Daugherty CK, Banik DM, Janish L, Ratain MJ. Quantitative analysis of ethical issues in phase 1 trials: a survey interview study of 144 advanced cancer patients. IRB. 2000;22(3):6-14.
29. Simon CM, Siminoff LA, Kodish ED, Burant C. Comparision of the informed consent process for randomized clinical trials in pediatric and adult oncology. J Clin Oncol. 2004;22(13):2708-2718.
30. Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007;4(11):e324.
31. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985;6(2):156-167.